• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1980 - 2014年苏格兰先天性甲状腺功能减退症新生儿筛查项目趋势:初次和重复采样后降低通知年龄的策略

Trends in Scottish newborn screening programme for congenital hypothyroidism 1980-2014: strategies for reducing age at notification after initial and repeat sampling.

作者信息

Mansour Chourouk, Ouarezki Yasmine, Jones Jeremy, Fitch Moira, Smith Sarah, Mason Avril, Donaldson Malcolm

机构信息

Hôpital Universitaire d'Enfants Abderrahim Harouchi, Casablanca, Morocco.

Etablissement Public Hospitalier Hassen-Badi, El-Harrach, Algiers, Algeria.

出版信息

Arch Dis Child. 2017 Oct;102(10):936-941. doi: 10.1136/archdischild-2016-312156. Epub 2017 Jun 9.

DOI:10.1136/archdischild-2016-312156
PMID:28600385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5739820/
Abstract

OBJECTIVES

To determine ages at first capillary sampling and notification and age at notification after second sampling in Scottish newborns referred with elevated thyroid-stimulating hormone (TSH).

SUBJECTS AND METHODS

Referrals between 1980 and 2014 inclusive were grouped into seven 5-year blocks and analysed according to agreed standards.

RESULTS

Of 2 116 132 newborn infants screened, 919 were referred with capillary TSH elevation ≥8 mU/L of whom 624 had definite (606) or probable (18) congenital hypothyroidism. Median age at first sampling fell from 7 to 5 days between 1980 and 2014 (standard 4-7 days), with 22, 8 and 3 infants sampled >7 days during 2000-2004, 2005-2009 and 2010-2014. Median age at notification was consistently ≤14 days, range falling during 2000-2004, 2005-2009 and 2010-2014 from 6 to 78, 7-52 and 7-32 days with 12 (14.6%), 6 (5.6%) and 5 (4.3%) infants notified >14 days. However 18/123 (14.6%) of infants undergoing second sampling from 2000 onwards breached the ≤26-day standard for notification. By 2010-2014, the 91 infants with confirmed congenital hypothyroidism had shown favourable median age at first sample (5 days) with start of treatment (10.5 days) approaching age at notification.

CONCLUSION

Most standards for newborn thyroid screening are being met by the Scottish programme, but there is a need to reduce age range at notification, particularly following second sampling. Strategies to improve screening performance include carrying out initial capillary sampling as close to 96 hours as possible; introducing 6-day laboratory reporting and use of electronic transmission for communicating repeat requests.

摘要

目的

确定因促甲状腺激素(TSH)升高而被转诊的苏格兰新生儿首次进行毛细血管采血及通知的年龄,以及第二次采血后通知的年龄。

对象与方法

将1980年至2014年(含)期间的转诊病例分为7个5年组,并按照商定的标准进行分析。

结果

在2116132例接受筛查的新生儿中,919例因毛细血管TSH升高≥8 mU/L而被转诊,其中624例患有明确(606例)或可能(18例)的先天性甲状腺功能减退症。1980年至2014年期间,首次采血的中位年龄从7天降至5天(标准为4 - 7天),在2000 - 2004年、2005 - 2009年和2010 - 2014年期间,分别有22例、8例和3例婴儿在>7天时采血。通知的中位年龄始终≤14天,在2000 - 2004年、2005 - 2009年和2010 - 2014年期间,范围从6至78天、7至52天和7至32天下降,分别有12例(14.6%)、6例(5.6%)和5例(4.3%)婴儿在>14天时被通知。然而,2000年起接受第二次采血的婴儿中有18/123(14.6%)违反了≤26天的通知标准。到2010 - 2014年,91例确诊先天性甲状腺功能减退症的婴儿首次采样的中位年龄(5天)良好,治疗开始时间(10.5天)接近通知年龄。

结论

苏格兰的新生儿甲状腺筛查项目大多符合标准,但有必要缩小通知的年龄范围,尤其是在第二次采血之后。提高筛查性能的策略包括尽可能在接近96小时时进行首次毛细血管采血;引入6天的实验室报告,并使用电子传输来传达重复请求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/5739820/e61372a9c064/archdischild-2016-312156f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/5739820/b618e4230f0c/archdischild-2016-312156f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/5739820/e61372a9c064/archdischild-2016-312156f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/5739820/b618e4230f0c/archdischild-2016-312156f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/5739820/e61372a9c064/archdischild-2016-312156f02.jpg

相似文献

1
Trends in Scottish newborn screening programme for congenital hypothyroidism 1980-2014: strategies for reducing age at notification after initial and repeat sampling.1980 - 2014年苏格兰先天性甲状腺功能减退症新生儿筛查项目趋势:初次和重复采样后降低通知年龄的策略
Arch Dis Child. 2017 Oct;102(10):936-941. doi: 10.1136/archdischild-2016-312156. Epub 2017 Jun 9.
2
Audit of screening programme for congenital hypothyroidism in Scotland 1979-93.1979 - 1993年苏格兰先天性甲状腺功能减退症筛查项目审计
Arch Dis Child. 1997 May;76(5):411-5. doi: 10.1136/adc.76.5.411.
3
How well does the capillary thyroid-stimulating hormone test for newborn thyroid screening predict the venous free thyroxine level?用于新生儿甲状腺筛查的毛细血管促甲状腺激素检测对静脉游离甲状腺素水平的预测效果如何?
Arch Dis Child. 2016 Jun;101(6):539-545. doi: 10.1136/archdischild-2015-309529. Epub 2016 Mar 10.
4
Improvement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979-2003.1979 - 2003年苏格兰先天性甲状腺功能减退症筛查性能及诊断的改善情况
Arch Dis Child. 2006 Aug;91(8):680-5. doi: 10.1136/adc.2005.088427. Epub 2006 Apr 4.
5
Repeat testing for congenital hypothyroidism in preterm infants is unnecessary with an appropriate thyroid stimulating hormone threshold.对于早产儿,采用适当的促甲状腺激素阈值进行先天性甲状腺功能减退症的重复检测是不必要的。
Arch Dis Child Fetal Neonatal Ed. 2008 Jul;93(4):F286-8. doi: 10.1136/adc.2007.134999. Epub 2008 Feb 5.
6
Optimal Timing of Repeat Newborn Screening for Congenital Hypothyroidism in Preterm Infants to Detect Delayed Thyroid-Stimulating Hormone Elevation.早产儿先天性甲状腺功能减退症重复新生儿筛查以检测延迟促甲状腺激素升高的最佳时机。
J Pediatr. 2019 Feb;205:77-82. doi: 10.1016/j.jpeds.2018.09.044. Epub 2018 Oct 24.
7
Evaluation of the revised New Zealand national newborn screening protocol for congenital hypothyroidism.新西兰先天性甲状腺功能减退症国家新生儿筛查修订方案的评估。
Clin Endocrinol (Oxf). 2017 Mar;86(3):431-437. doi: 10.1111/cen.13250. Epub 2016 Oct 21.
8
Permanent congenital hypothyroidism with blood spot thyroid stimulating hormone <10 mU/L.血斑促甲状腺激素<10 mU/L的永久性先天性甲状腺功能减退症
Arch Dis Child. 2018 Jan;103(1):65-67. doi: 10.1136/archdischild-2015-309564. Epub 2016 Mar 25.
9
Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism.早产儿先天性甲状腺功能减退症筛查检测到的甲状腺功能演变。
J Pediatr. 2014 Jun;164(6):1296-302. doi: 10.1016/j.jpeds.2013.12.048. Epub 2014 Feb 8.
10
Newborn Screening in the US May Miss Mild Persistent Hypothyroidism.美国的新生儿筛查可能会漏诊轻度持续性甲状腺功能减退症。
J Pediatr. 2018 Jan;192:204-208. doi: 10.1016/j.jpeds.2017.09.003.

引用本文的文献

1
First Experiences with Newborn Screening for Congenital Hypothyroidism in Ulaanbaatar, Mongolia.蒙古国乌兰巴托先天性甲状腺功能减退症新生儿筛查的首次经验。
Int J Neonatal Screen. 2021 Jun 7;7(2):29. doi: 10.3390/ijns7020029.
2
[Risk factors for neonatal congenital hypothyroidism: a Meta analysis].[新生儿先天性甲状腺功能减退症的危险因素:一项Meta分析]
Zhongguo Dang Dai Er Ke Za Zhi. 2021 May;23(5):505-512. doi: 10.7499/j.issn.1008-8830.2011121.
3
Determination of thyroid volume in infants with suspected congenital hypothyroidism-the limitations of both subjective and objective evaluation.

本文引用的文献

1
How well does the capillary thyroid-stimulating hormone test for newborn thyroid screening predict the venous free thyroxine level?用于新生儿甲状腺筛查的毛细血管促甲状腺激素检测对静脉游离甲状腺素水平的预测效果如何?
Arch Dis Child. 2016 Jun;101(6):539-545. doi: 10.1136/archdischild-2015-309529. Epub 2016 Mar 10.
2
European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.欧洲儿科内分泌学会关于先天性甲状腺功能减退症筛查、诊断和管理的共识指南。
J Clin Endocrinol Metab. 2014 Feb;99(2):363-84. doi: 10.1210/jc.2013-1891. Epub 2014 Jan 21.
3
Optimising outcome in congenital hypothyroidism; current opinions on best practice in initial assessment and subsequent management.
疑似先天性甲状腺功能减退症婴儿甲状腺体积的测定——主观和客观评估的局限性
BJR Open. 2020 Jun 10;2(1):20200001. doi: 10.1259/bjro.20200001. eCollection 2020.
4
NEONATAL SCREENING FOR CONGENITAL HYPOTHYROIDISM IN ROMANIA: DATA FROM MEDILOG MEDICAL INFORMATION REGISTRY.罗马尼亚先天性甲状腺功能减退症的新生儿筛查:来自Medilog医学信息登记处的数据。
Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):209-214. doi: 10.4183/aeb.2019.209.
5
Newborn Screening and Molecular Profile of Congenital Hypothyroidism in a Chinese Population.中国人群先天性甲状腺功能减退症的新生儿筛查及分子特征
Front Genet. 2018 Oct 29;9:509. doi: 10.3389/fgene.2018.00509. eCollection 2018.
6
Transient hypothyroidism in the newborn: to treat or not to treat.新生儿短暂性甲状腺功能减退症:治疗与否
Transl Pediatr. 2017 Oct;6(4):349-358. doi: 10.21037/tp.2017.09.07.
优化先天性甲状腺功能减退症的治疗效果;关于初始评估及后续管理最佳实践的当前观点
J Clin Res Pediatr Endocrinol. 2013;5 Suppl 1(Suppl 1):13-22. doi: 10.4274/jcrpe.849. Epub 2012 Nov 15.
4
Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.密歇根州新生儿免疫反应性胰蛋白酶原浓度的差异及其对囊性纤维化新生儿筛查的影响。
Pediatr Pulmonol. 2011 Feb;46(2):125-30. doi: 10.1002/ppul.21330. Epub 2010 Sep 16.
5
Audit of initial management of congenital hypothyroidism in the United Kingdom--comparison of UK practice with European and UK guidelines.英国先天性甲状腺功能减退症初始管理的审计——英国实践与欧洲及英国指南的比较。
J Pediatr Endocrinol Metab. 2009 Nov;22(11):1017-25. doi: 10.1515/jpem.2009.22.11.1017.
6
Expanded newborn screening: Lessons learned from MCAD deficiency.扩大新生儿筛查:从甲基丙二酸血症(MCAD)缺乏症中吸取的教训。
Paediatr Child Health. 2004 Apr;9(4):241-3. doi: 10.1093/pch/9.4.241.
7
A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system.关于清晰性、一致性和实用性的案例:采用推荐分级、评估、制定和评价系统的内分泌学最新临床实践指南
J Clin Endocrinol Metab. 2008 Mar;93(3):666-73. doi: 10.1210/jc.2007-1907. Epub 2008 Jan 2.
8
Improvement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979-2003.1979 - 2003年苏格兰先天性甲状腺功能减退症筛查性能及诊断的改善情况
Arch Dis Child. 2006 Aug;91(8):680-5. doi: 10.1136/adc.2005.088427. Epub 2006 Apr 4.
9
Earlier onset of treatment or increment in LT4 dose in screened congenital hypothyroidism: which as the more important factor for IQ at 7 years?筛查出的先天性甲状腺功能减退症中治疗的早期开始或左甲状腺素(LT4)剂量的增加:哪一个是7岁时智商的更重要因素?
Horm Res. 2004;61(5):228-33. doi: 10.1159/000076597.
10
Audit of screening programme for congenital hypothyroidism in Scotland 1979-93.1979 - 1993年苏格兰先天性甲状腺功能减退症筛查项目审计
Arch Dis Child. 1997 May;76(5):411-5. doi: 10.1136/adc.76.5.411.